ES8101073A1 - Procedimiento para la preparacion de derivados de (ergo- lin-il)-n',n'-dietilurea - Google Patents

Procedimiento para la preparacion de derivados de (ergo- lin-il)-n',n'-dietilurea

Info

Publication number
ES8101073A1
ES8101073A1 ES492400A ES492400A ES8101073A1 ES 8101073 A1 ES8101073 A1 ES 8101073A1 ES 492400 A ES492400 A ES 492400A ES 492400 A ES492400 A ES 492400A ES 8101073 A1 ES8101073 A1 ES 8101073A1
Authority
ES
Spain
Prior art keywords
ergolin
preparation
pharmaceutical compositions
compositions containing
urea derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES492400A
Other languages
English (en)
Other versions
ES492400A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19792924102 external-priority patent/DE2924102A1/de
Priority claimed from DE19803016691 external-priority patent/DE3016691A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of ES8101073A1 publication Critical patent/ES8101073A1/es
Publication of ES492400A0 publication Critical patent/ES492400A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE DERIVADOS DE (ERGOLIN-IL)-N'',N''-DIETILUREA. CONSTA DE LAS SIGUIENTES ETAPAS: 1) REACCION DE LOS ETERES METILICOS DE ACIDOS LISERGICOS ALCOHILADOS EN N CON HIDRAZINA ANHIDRA, PARA FORMAR LOS HIDRAZIDA CORRESPONDIENTES. 2) TRANSFORMACION DE LA HIDRAZIDA OBTENIDA, CON ACIDO NITROSO EN LA AZIDA DE ACIDO, LA MEZCLA SE AGREGA A UN TAMPON TAL COMO HIDROGENOCARBONATO SODICO, HIDROGENOFOSFATO DISODICO, ACETATO SODICO, BORATO POTASICO O AMONIO, Y ES EXTRAIDA CON TOLUENO. 3) CALENTAMIENTO DE LA FASE EN TOLUENO DESDE 70GC HASTA TEMPERATURA DE EBULLICION, FORMANDOSE EL CORRESPONDIENTE ISOCIANATO. 4) REACCION DEL ISOCIANATO OBTENIDO CON DIETILAMINA A TEMPERATURA AMBIENTE, LOS ISOMEROS OBTENIDOS SE SEPARAN POR CROMATOGRAFIA. ACTIVIDAD DOPAMINERGICA.
ES492400A 1979-06-13 1980-06-13 Procedimiento para la preparacion de derivados de (ergo- lin-il)-n',n'-dietilurea Granted ES492400A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19792924102 DE2924102A1 (de) 1979-06-13 1979-06-13 Neue (ergolin-yl)-n'.n'-diaethylharnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE19803016691 DE3016691A1 (de) 1980-04-28 1980-04-28 Neue (ergolin-yl)-n' .n'diaethylharnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel ii.

Publications (2)

Publication Number Publication Date
ES8101073A1 true ES8101073A1 (es) 1980-12-16
ES492400A0 ES492400A0 (es) 1980-12-16

Family

ID=25779537

Family Applications (1)

Application Number Title Priority Date Filing Date
ES492400A Granted ES492400A0 (es) 1979-06-13 1980-06-13 Procedimiento para la preparacion de derivados de (ergo- lin-il)-n',n'-dietilurea

Country Status (14)

Country Link
US (1) US4379790A (es)
EP (1) EP0021206B1 (es)
AU (1) AU541679B2 (es)
CA (1) CA1140922A (es)
CS (1) CS223809B2 (es)
DD (1) DD151449A5 (es)
DE (1) DE3063869D1 (es)
DK (1) DK149059C (es)
ES (1) ES492400A0 (es)
HU (1) HU184786B (es)
IE (1) IE49991B1 (es)
IL (1) IL60261A (es)
SU (1) SU965356A3 (es)
YU (1) YU41929B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982000463A1 (en) * 1980-07-25 1982-02-18 Ag Sandoz Ergoline derivatives,method for their preparation,pharmaceutical compositions containing them and their therapeutic application
CH644606A5 (de) * 1980-09-23 1984-08-15 Sandoz Ag Verfahren zur isomerisierung von 9,10-dihydrolysergsaeurederivaten.
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3135305C2 (de) * 1981-09-03 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 8-Ergolinyl-harnstoffen
DE3151912A1 (de) * 1981-12-23 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
CS231214B1 (en) * 1982-03-12 1984-10-15 Antonin Cerny Processing method of 1-substituted n+l8alpha-ergoline+p-n,diethyl urea
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
DE3445784A1 (de) * 1984-12-13 1986-06-26 Schering AG, Berlin und Bergkamen, 1000 Berlin Verfahren zur herstellung von ergolin-derivaten
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.
EP0208417A3 (en) * 1985-06-12 1989-09-06 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
DE3528576A1 (de) * 1985-08-06 1987-02-19 Schering Ag Verfahren zur herstellung von ergolin-thioharnstoffen
DE3533672A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-substituierte ergolinderivate
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10226459A1 (de) * 2002-06-13 2004-01-08 Neurobiotec Gmbh Verwendung von Dopamin-Partialagonisten zur Behandlung des Restless Legs Syndroms
GB0307377D0 (en) * 2003-03-31 2003-05-07 Merad Pharmaceuticals Ltd Ergoline derivatives
EP2083008A1 (en) * 2007-12-07 2009-07-29 Axxonis Pharma AG Ergoline derivatives as selective radical scavengers for neurons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1212097B (de) * 1962-09-05 1966-03-10 Sdruzeni Podnikuu Pro Zdravotn Verfahren zur Herstellung von N-[D-1, 6-Dimethylisoergolenyl-(8)]-N', N'-dialkylharnstoffen
CH430738A (de) * 1962-09-05 1967-02-28 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung von N-(D-1,6-Dimethyl-isoergolenyl-8)-N',N'-dialkyl-harnstoffen
US3681497A (en) * 1966-06-07 1972-08-01 Spofa Vereinigte Pharma Werke Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide
FR1536759A (fr) * 1966-09-14 1968-08-16 Spofa Vereinigte Pharma Werke Procédé de préparation de la n-/d-6-méthyl-8-isoergolényl/-n', n'-diéthyl-urée
CH573937A5 (es) * 1971-08-05 1976-03-31 Spofa Vereinigte Pharma Werke
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
JPS5448880A (en) * 1977-09-02 1979-04-17 Tetra Pak Int Method of designing packaging laminate and packaging laminate

Also Published As

Publication number Publication date
US4379790A (en) 1983-04-12
DK149059B (da) 1986-01-06
DK149059C (da) 1986-07-14
IE801210L (en) 1980-12-13
DK252680A (da) 1980-12-14
YU41929B (en) 1988-02-29
CS223809B2 (en) 1983-11-25
EP0021206A1 (de) 1981-01-07
IL60261A0 (en) 1980-09-16
ES492400A0 (es) 1980-12-16
DE3063869D1 (en) 1983-07-28
HU184786B (en) 1984-10-29
AU5913580A (en) 1980-12-18
IE49991B1 (en) 1986-01-22
YU154480A (en) 1983-09-30
DD151449A5 (de) 1981-10-21
SU965356A3 (ru) 1982-10-07
AU541679B2 (en) 1985-01-17
CA1140922A (en) 1983-02-08
IL60261A (en) 1983-10-31
EP0021206B1 (de) 1983-06-22

Similar Documents

Publication Publication Date Title
ES8101073A1 (es) Procedimiento para la preparacion de derivados de (ergo- lin-il)-n',n'-dietilurea
ATE23716T1 (de) 5,6,7-trinor-4,8-inter-m-phenylen-prostaglandin i2-derivate.
CA1251209A (en) DISHYDROPYRIDAZINONE DERIVATIVES
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ES8500948A1 (es) Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES8306142A1 (es) "procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil)-bencimidazolonas sustituidas".
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
IL64745A0 (en) (2-haloergolinyl)-n',n'-diethylurea derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
KR900006296A (ko) 이미다졸린 유도체 및 그의 제조방법
ES8403928A1 (es) Un procedimiento para la preparacion de nuevas macrolidas antibioticas.
ES8609225A1 (es) Un procedimiento para preparar un derivado de semicarbazida
IL77124A0 (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compounds,their preparation and pharmaceutical compositions containing them
IL64647A (en) 2,8-disubstituted-4-thiomorpholino-pyrimido(5,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ES8800253A1 (es) Un procedimiento para preparar derivados sinteticos de pseudopterosina
IL66694A0 (en) Dibenzazepine derivatives,their preparation and pharmaceutical compositions containing them
ZA836090B (en) Thieno-thiazole derivatives,processes for preparing these compounds,and pharmaceutical compositions thereof
IL85725A (en) Imidazole derivatives,their manufacture and pharmaceutical compositions containing them
GB1494560A (en) 4-aryl-5-aminoalkyl-4-thiazolin-2-ones and their preparation
IL65316A (en) 7alpha-alkoxycarbonyl-15beta,16beta-methylene-4-androstenes and pharmaceutical preparations containing the same
DE3362876D1 (en) Dibenzocycloheptenylidene compounds for use in modulating the immune response
ES8403130A1 (es) Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas.
ES8507524A1 (es) Un procedimiento para preparar derivados de tropona
ES8607944A1 (es) Procedimiento para la preparacion de nuevos derivados de 1- fenilimidazolidin-2-ona
DE3361670D1 (en) N-substituted imidazole derivatives, their preparation, pharmaceutical compositions containing them and their use
GB1480892A (en) 3-nitropyrazole derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519